Phase 1 Alzheimer's Disease Trial, Recruiting NCT07386730 Sponsor: Jennifer Mitchell Condition: Alzheimer's Disease
Back to Alzheimers Disease

Phase 1 Alzheimer's Disease Trial, Recruiting

NCT07386730
Recruiting Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 50 and 85 years old (inclusive) at the time you sign the consent form
  • You have below-average well-being, as measured by a standard questionnaire called the WHO-5 Well-Being Index
  • You do not have significant memory or thinking problems, based on a standard mental assessment test score above 24
  • You have someone in your life (such as a family member or friend) who sees or speaks with you at least once a week, is willing to provide information about how you are doing day-to-day, and can drive or accompany you home after the main study visit
  • If you were assigned female at birth, you are not breastfeeding and have gone through menopause (no period for more than 12 months) or are otherwise physically unable to become pregnant
  • If you were assigned male at birth, you agree not to donate sperm for 3 months after the main study visit, and if you could cause a pregnancy through sexual activity, you agree to use a condom plus ensure your partner uses a second reliable form of contraception for 3 months after the main study visit
  • You are fluent in English
  • You are able to understand what the study involves and can give your informed consent
  • You are willing and available to follow all study procedures for the full duration of the study
  • You are able to swallow capsules

Who may not be able to join:

  • You have had a known allergic or serious reaction to psilocybin, dextromethorphan, or any inactive ingredients in the study capsules
  • You are unable to reliably report on your own symptoms in a way that would allow valid study assessments
  • You have any condition or feature that the study doctors believe could interfere with your participation or make it harder to interpret the study results (confirm with trial site)
  • You have any implanted metal object or electronic device in your body that could make an MRI scan unsafe or interfere with it — examples include pacemakers, cochlear implants, certain joint replacements, vascular stents, or similar devices (confirm with trial site for the full list)
  • You have a history of a metal injury to your eyes or body, or have tattoos with metallic ink, permanent makeup, or body piercings that cannot be removed
  • You have any condition that could make an MRI scan unsafe or difficult, such as severe claustrophobia, certain movement disorders, or breathing problems
  • You have a history of a condition called hallucinogen persisting perception disorder (HPPD), as defined by standard psychiatric guidelines
  • You have a significant heart or cardiovascular condition, such as a serious irregular heartbeat, a mini-stroke in the last 6 months, a history of bleeding stroke, or a heart attack within the past year
  • Your resting heart rate is below 60 or above 90 beats per minute at screening or before dosing
  • You have high blood pressure (confirmed by repeated measurements)
  • You have an abnormal heart rhythm measurement on an ECG (a test that checks heart electrical activity) above a certain threshold
  • You have a significant uncontrolled heart rhythm problem, such as uncontrolled atrial fibrillation
  • You experience palpitations, chest pain, or fainting during physical activity
  • You have a major ongoing health condition such as epilepsy/seizures, insulin-dependent diabetes, advanced cancer or recent cancer treatment (within the last 12 months), or have had major surgery in the last 6 months or plan to have surgery during the study
  • Your liver is not functioning well enough, based on blood test results (confirm with trial site) — note: people with a condition called Gilbert syndrome are allowed to join
  • Your kidneys are not functioning well enough, based on a standard blood test measurement
  • You are considered to be at an increased risk of falling

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Lorenzo Pasquini, PhD, University of California, San Francisco

Phone: 415-707-5399

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 1
Sponsor
Jennifer Mitchell
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 February 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acute changes in EEG-based ESBA

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov